The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study
Kang Liang,
Jianwei Liu,
Xiaorong Pan,
Yuxuan Lin,
Kongying Lin,
Hui Xue,
Jing Li,
Huichuan Sun,
Kui Wang,
China Liver Cancer Study Group Young Investigators (CLEAP) Cancer Medicine
· Wiley
· 2026-11-06
· DOI: 10.1002/cam4.72415
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Kang Liang, Jianwei Liu, Xiaorong Pan, Yuxuan Lin, Kongying Lin, Hui Xue et al. The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study. // Cancer Medicine. – 2026. – DOI: 10.1002/cam4.72415. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cam4.72415?af=R
Kang Liang, Jianwei Liu, Xiaorong Pan, Yuxuan Lin, Kongying Lin, Hui Xue, Jing Li, Huichuan Sun, Kui Wang, & China Liver Cancer Study Group Young Investigators (CLEAP) (2026). The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.72415
Kang Liang, et al. “The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study.” Cancer Medicine, 2026. doi:10.1002/cam4.72415.
@article{Liang2026,
title = {The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study},
author = {Liang, Kang and Liu, Jianwei and Pan, Xiaorong and Lin, Yuxuan and Lin, Kongying and Xue, Hui and Li, Jing and Sun, Huichuan and Wang, Kui and (CLEAP), China Liver Cancer Study Group Young Investigators},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72415},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cam4.72415?af=R}
}